Recent advances in the genetics of systemic lupus erythematosus

Expert Rev Clin Immunol. 2010 May;6(3):461-79. doi: 10.1586/eci.10.8.

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the production of antinuclear autoantibodies and the inflammatory infiltration of many organ systems. SLE is a complex disorder in which multiple genetic variants, together with environmental and hormonal factors, contribute to disease risk. In this article, we summarize our current understanding of the genetic contribution to SLE in light of recent genome-wide association studies, which have brought the total number of confirmed SLE susceptibility loci to 29. In the second section, we explore the functional implications of these risk loci and, in particular, highlight the role that many of these genes play in the Toll-like receptor and type I interferon signaling pathways. Finally, we discuss the genetic overlap between SLE and other autoimmune and inflammatory conditions as several risk loci are shared among multiple disorders, suggesting common underlying pathogenic mechanisms.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Animals
  • Arthritis, Rheumatoid / genetics
  • Arthritis, Rheumatoid / immunology
  • Autoantibodies / genetics
  • Autoantibodies / immunology
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology
  • Female
  • Genetic Association Studies
  • Genetic Loci
  • Genetic Predisposition to Disease*
  • Humans
  • Interferon Type I / genetics
  • Interferon Type I / immunology
  • Lupus Erythematosus, Systemic / genetics*
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Mice
  • Risk Factors
  • Toll-Like Receptors / genetics
  • Toll-Like Receptors / immunology
  • Young Adult

Substances

  • Autoantibodies
  • Interferon Type I
  • Toll-Like Receptors